tiprankstipranks
Trending News
More News >
Neurosense Therapeutics Ltd. (NRSN)
NASDAQ:NRSN
US Market

Neurosense Therapeutics Ltd. (NRSN) Financial Statements

Compare
180 Followers

Neurosense Therapeutics Ltd. Financial Overview

Neurosense Therapeutics Ltd.'s market cap is currently $30.59M. The company's EPS TTM is $-0.04; its P/E ratio is -1.87; Neurosense Therapeutics Ltd. is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ -89.00K$ -3.00K$ -3.00K
Operating Income$ -9.90M$ -12.05M$ -13.55M$ -5.59M$ -2.89M
EBITDA$ -9.88M$ -9.64M$ -12.23M$ -2.88M$ -2.83M
Net Income$ -10.21M$ -10.11M$ -12.34M$ -4.04M$ -2.83M
Balance Sheet
Cash & Short-Term Investments$ 3.38M$ 2.64M$ 7.09M$ 11.06M$ 699.00K
Total Assets$ 4.58M$ 3.18M$ 7.71M$ 11.43M$ 779.00K
Total Debt$ 73.00K$ 142.00K$ 211.00K$ 1.83M$ 0.00
Net Debt$ -3.31M$ -2.50M$ -3.33M$ -9.23M$ -699.00K
Total Liabilities$ 1.99M$ 4.94M$ 2.09M$ 2.42M$ 120.00K
Stockholders' Equity$ 2.58M$ -1.87M$ 5.62M$ 9.01M$ 659.00K
Cash Flow
Free Cash Flow$ -10.14M$ -8.38M$ -7.66M$ -1.56M$ -704.00K
Operating Cash Flow$ -10.13M$ -8.35M$ -7.59M$ -1.54M$ -695.00K
Investing Cash Flow$ 1.00K$ 3.47M$ -3.54M$ -17.00K$ -9.00K
Financing Cash Flow$ 10.91M$ 3.98M$ 3.69M$ 11.90M$ 508.00K
Currency in USD

Neurosense Therapeutics Ltd. Earnings and Revenue History

Neurosense Therapeutics Ltd. Debt to Assets

Neurosense Therapeutics Ltd. Cash Flow

Neurosense Therapeutics Ltd. Forecast EPS vs Actual EPS